This article presents a mechanistic study of silver nanodecahedra prepared by the method of photoassisted sodium citrate reduction under irradiation of blue light-emitting diodes (LEDs). This synthesis of silver nanodecahedra can be easily reproduced in the absence of silver seeds and can be completed in one-pot. The data suggest a combination of two processes including gradual growth from multiple-twinned particles and subsequent plasmonmediated crystal growth. More than 85% of as-prepared silver nanoparticles are decahedra with edge lengths of 43.5 ± 5.2 nm. In addition, the as-prepared silver colloids exhibit a spectroscopic enhancement in comparison with spherical silver nanoparticle colloids and silver nanoprism colloids in the measurement of surface enhanced Raman spectroscopy (SERS) spectra of Rhodamin 6G, and with the decahedral silver colloids synthesized in the presence of PVP for detecting SERS signal of Rhodamin 6G. Overall, this photoassisted citrate reduction process is simple, and highly reproducible. As-prepared silver nanodecahedra are more stable and provide optimal SERS signal than those synthesized using commonly used plasmon-mediated photochemical methods.

Background Photodynamic therapy (PDT) is an effective therapy for cancers and is a minimally invasive therapy with low dark toxicity and limited side effects. PDT employs the combination of photosensitizers with a specific light source to produce reactive oxygen species (ROS) to damage tumor cells. Methods We fabricated nanoparticles encapsulating curcumin through crosslinking chitosan and tripolyphosphate (TPP). Additionally, the chitosan was conjugated to epidermal growth factor in order to target the epidermal growth factor receptor (EGFR), overexpressed on cancer cells. To investigate PDT using fabricated nanoparticles, we measured cell viabilities and ROS production in relation to EGFR-overexpressing gastric cancer cells and non-cancer gastric cells. Results The targeting nanoparticles displayed a superior PDT effect in the cancer cell, with a resultant approximately fourfold decrease in the IC 50 . The PDT mechanism of curcumin-encapsulated nanoparticles is further identified as the generation of 1 O 2 , the major pathway in PDT. Conclusion These curcumin-encapsulated chitosan/TPP nanoparticles are a promising targeted-PDT against EGFR-overexpressing cancers.

Misfolding and aggregation into amyloids of the prion protein (PrP) is responsible for the development of fatal transmissible neurodegenerative diseases. Various studies on curcumin demonstrate promise for the prevention of Alzheimer’s disease and inhibition of PrPres accumulation. To evaluate the effect of curcumin on amyloid fibrillation of prion protein, we first investigated the effect of curcumin on mouse prion protein (mPrP) in a cell-free system. Curcumin reduced the prion fibril formation significantly. Furthermore, we monitored the change in apoptosis and reactive oxygen species (ROS) level upon curcumin treatment in mouse neuroblastoma cells (N2a). Curcumin effectively rescues the cells from apoptosis and decreases the ROS level caused by subsequent co-incubation with prion amyloid fibrils. The assays in cell-free mPrP and in N2a cells of this work verified the promising effect of curcumin on the prevention of transmissible neurodegenerative diseases.

The solar water-splitting protein complex, photosystem II, catalyzes one of the most energetically demanding reactions in Nature by using light energy to drive the catalytic oxidation of water. Photosystem II contains two symmetrically placed tyrosine residues, YD and YZ, one on each subunit of the heterodimeric core. The YZ residue is kinetically competent and is proposed to be directly involved in the proton-coupled electron transfer reactions of water oxidation. In contrast, the YD proton-coupled electron transfer redox poises the catalytic tetranuclear manganese cluster and may electrostatically tune the adjacent monomeric redox-active chlorophyll and β-carotene in the secondary electron transfer pathway of photosystem II. In this study, we apply pulsed high-frequency electron paramagnetic resonance (EPR) and electron nuclear double-resonance (ENDOR) spectroscopy to study the photochemical proton-coupled electron transfer (PCET) intermediates of YD. We detect the "unrelaxed" and "relaxed" photoinduced PCET intermediates of YD using high-frequency EPR spectroscopy and observe an increase of the g anisotropy upon temperature-induced relaxation of the unrelaxed intermediate to the relaxed state as previously observed by Faller et al. [(2002) Biochemistry 41, 12914-12920; (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 8732-8735]. This observation suggests the presence of structural differences between the two intermediates. We probe the possible structural differences by performing high-frequency (2)H ENDOR spectroscopy experiments. On the basis of numerical simulations of the experimental (2)H ENDOR spectra, we confirm that (i) there is a significant change in the H-bond length of the tyrosyl radical in the unrelaxed (1.49 Å) and relaxed (1.75 Å) PCET intermediates. This observation suggests that the D2-His189 residue is deprotonated prior to electron transfer at the YD residue and (ii) there are negligible changes in the conformation of the tyrosyl ring in the unrelaxed and relaxed PCET intermediates of YD.

Candida albicans is the most commonly encountered human fungal pathogen, and it is traditionally treated with antimicrobial chemical agents. The antimicrobial effect of these agents is largely weakened by drug resistance and biofilm-associated virulence. Enhancement of the antimicrobial activity of existing agents is needed for effective candidiasis treatment. Our aim was to develop a therapy that combined biofilm disruption with existing antimicrobial agents. Photodynamic therapy (PDT) utilizing curcumin and blue light was tested as an independent therapy and in combination with fluconazole treatment. Viability assays and morphology analysis were used to assess the effectiveness of C. albicans treatment. Results showed that fluconazole treatment decreased the viability of planktonic C. albicans, but the decrease was not as pronounced in adherent C. albicans because its biofilm form was markedly more resistant to the antimicrobiotic. PDT effectively eradicated C. albicans biofilms, and when combined with fluconazole, PDT significantly inhibited C. albicans to a greater extent. This study suggests that the addition of PDT to fluconazole to treat C. albicans infection enhances its effectiveness and can potentially be used clinically.